New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis

NEXT STORY
Blood Sugar Blaster Reviews – Supplement Ingredients List & Side Effects!! by DietCare Reviews
PREV STORY
BioFit Probiotic Review: Risky Scam or Real Customer Results (April 2021 Updates)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Meningitis Infection Drug Pipeline Study, H2 2018 – Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline

Dublin, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The "Meningitis Infection Drug Pipeline Study, H2 ...

author_avatar
NASDAQ Market News

Acacia Pharma’s BARHEMSYS Significantly Improves Post-operative Nausea & Vomiting (PONV) in Rescue Treatment of Ambulatory Patients

author_avatar
NASDAQ Market News

VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority

author_avatar
NASDAQ Market News